Role of the Lung in Accumulation and Metabolism of Xenobiotic Compounds — Implications for Chemically Induced Toxicity

References

• Murray J. F. The Normal Lung. W. B. Saunders Company, Philadelphia 1976; 53
   Google Scholar
• Bend J. R., Serabjit Singh C. J., Philpot R. M. The pulmonary uptake, accumulation, and metabolism of xenobiotics. Annu. Rev. Pharmacol. Toxicol. 1985; 25: 97
   PubMed Web of Science ®Google Scholar
• Cohen G. M. Pulmonary metabolism of foreign compounds: its role in metabolic activation. Environ. Health Perspect. 1990; 85: 31
   PubMed Web of Science ®Google Scholar
• Gram T. E. The pulmonary mixed-function oxidase system. Toxicology of Inhaled Materials, Handbook of Experimental Pliarmacology, H. P. Witschi, J. D. Brain. Springer-Verlag, Berlin 1985; Vol. 75: 421
   Google Scholar
• Bond J. A. Metabolism and elimination of inhaled drugs and airborne chemicals from the lungs. Pharmacol. Toxicol 1993; 72(Suppl. 3)36
   PubMedGoogle Scholar
• Roth R. A., Vinegar A. Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition. Pharmacol. Ther. 1990; 48: 143
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Purification and characterization of xenobiotic-metabolizing enzymes from lung tissue. Pharmacol. Ther. 1990; 45: 299
   PubMed Web of Science ®Google Scholar
• Baron J., Voigt J. M. Localization, distribution, and induction of xenobiotic-metabolizing enzymes and aryl hydrocarbon hydroxylase activity within lung. Pharmacol. Ther. 1990; 47: 419
   PubMed Web of Science ®Google Scholar
• Lehnert B. E., Valdez Y. E., Bomalaski S. H. Lung and pleural “free-cell responses” to the intrapulmonary deposition of particles in the rat. J. Toxicol. Environ. Health 1985; 16: 823
   PubMed Web of Science ®Google Scholar
• Thiedemann K. U., Nolte T., Rittinghausen S., Ernst H. Immunohistochemistry and morphology of particle-induced pulmonary lesions. Prog. Histochem. Cytochem. 1991; 23: 200
   PubMedGoogle Scholar
• Ayars G. H., Altman L. C., O'Neil C. E., Butcher B. T., Chi E. Y. Cotton dust-mediated lung epithelial injury. J. Clin. Invest. 1986; 78: 1579
   PubMed Web of Science ®Google Scholar
• Cua W. O., Basset G., Bouchonnet F., Garrick R. A., Saumon G., Chinard F. P. Endothelial and epithelial permeabilities to antipyrine in rat and dog lungs. Am. J. Physiol. 1990; 258: H1321
   Google Scholar
• Kröll F., Karlsson J. A., Nilsson E., Ryrfeldt A., Persson C. G. A. Rapid clearance of xanthines from airway and pulmonary tissues. Am. Rev. Respir. Dis. 1990; 141: 1167
   PubMedGoogle Scholar
• Crandall E. D., Heming T. A., Palombo R. L., Goodman B. E. Effects of terbutaline on sodium transport in isolated perfused rat lung. J. Appl. Physiol. 1986; 60: 289
   PubMed Web of Science ®Google Scholar
• Folkesson H. G., Westrom B. R., Pierzynowski S. G., Karlsson B. W. Lung to blood passage of different-sized molecules during lung inflammation in the rat. J. Appl. Physiol. 1991; 71: 1106
   PubMed Web of Science ®Google Scholar
• Saumon G., Basset G., Bouchonnet F., Crone C. Cellular effects of β-adrenergic and of cAMP stimulation of potassium transport in rat alveolar epithelium. Pflügers Arch. 1989; 414: 340
   PubMedGoogle Scholar
• Chinard F. P., De Fouw D. O. Pulmonary transport of water and solutes: functional and structural correlations. Fed. Proc. 1983; 42: 2435
   PubMedGoogle Scholar
• Saumon G., Basset G. Electrolyte and fluid transport across the mature alveolar epithelium. J. Appl. Physiol. 1993; 74: 1
   PubMedGoogle Scholar
• Rutschman D. H., Olivera W., Sznajder I. Active transport and passive liquid movement in isolated perfused rat lungs. J. Appl. Physiol. 1993; 75: 1574
   PubMed Web of Science ®Google Scholar
• Niven R. W., Rypacek F., Byron P. R. Solute absorption from the airways of the isolated rat lung. III. Absorption of several peptidase-resistant, synthetic polypeptides: poly-(2-hydroxyethyl)-aspartamides. Pharm. Res. 1990; 7: 990
   PubMed Web of Science ®Google Scholar
• Niven R. W., Byron P. R. Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract. Pharm. Res. 1988; 5: 574
   PubMed Web of Science ®Google Scholar
• Niven R. W., Byron R. R. Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorptions of fluorescein. Pharm. Res. 1990; 7: 8
   PubMedGoogle Scholar
• Roerig D. L., Kotrly K. J., Ahlf S. B., Dawson C. A., Kampine J. P. Effect of propranolol on the first pass uptake of fentanyl in the human and rat lung. Anesthesiology 1989; 71: 62
   PubMed Web of Science ®Google Scholar
• Roerig D. L., Kotrly K. L., Vucins E. J., Ahlf S. B., Dawson C. A., Kampine J. P. First-pass uptake of fentanyl, meperidine, and morphine in the human lung. Anesthesiology 1987; 69: 466
   Google Scholar
• Roerig D. L., Dahl R. R., Dawson C. A., Wang R. I. Effect of plasma protein binding on the uptake of methadone and diazepam in the isolated perfused rat lung. Drug Metab. Dispos. 1984; 12: 536
   PubMed Web of Science ®Google Scholar
• Roerig D. L., Dahl R. R., Dawson C. A., Wang R. I. Uptake of 1-alpha-acetylmethadol (LAAM) and its analgesically active metabolites, nor LAAM and dinor-LAAM, in the isolated perfused rat lung. Drug Metab. Dispos. 1983; 11: 411
   PubMedGoogle Scholar
• Roerig D. L., Kotrly K. J., Dawson C. A., Ahlf S. B., Gualtieri J. F., Kampine J. P. First-pass uptake of verapamil, diazepam, and thiopental in the human lung. Anesthesiol. Analg. 1989; 67: 461
   Google Scholar
• Bertler A., Lewis D. H., Löfström J. B., Post C. In vivo lung uptake of lidocaine in pigs. Acta Anaesthesiol. Scand. 1978; 22: 530
   PubMedGoogle Scholar
• Jorfeldt L., Lewis D. H., Löfström J. B., Post C. Lung uptake of lidocaine in healthy volunteers. Acta Anaesthesiol. Scand. 1979; 23: 567
   PubMed Web of Science ®Google Scholar
• Post C., Andersson R. G. G., Ryrfeldt Ä., Nilsson E. Physico-chemical modification of lidocaine uptake in rat lung tissue. Acta Pharmacol. Toxicol. 1978; 44: 103
   Google Scholar
• Post C., Lewis D. H. Displacement of nortriptyline and uptake of 14C-lidocaine in the lung after administration of 14C-lidocaine to nortriptyline intoxicated pigs. Acta Pharmacol. Toxicol. 1979; 45: 218
   PubMedGoogle Scholar
• Post C., Eriksdotter-Behm K. Dependence of lung uptake of lidocaine in vivo on blood pH. Acta Pharmacol. Toxicol. 1982; 51: 136
   PubMedGoogle Scholar
• Jorfeld L., Lewis D. H., Löfström J. B., Post C. Lung uptake of lidocaine in man as influenced by anaesthesia, mepivacaine infusion or lung insufficiency. Acta Anaesthesiol. Scand. 1983; 27: 4
   Google Scholar
• Sakata K., Sakata M. Studies on the distribution of lidocaine in tissue after spinal and intravenous application in rabbits: clinical and forensic toxico-logical aspects. Clin. Toxicol. 1987; 25: 567
   Google Scholar
• Dollery C. T., Junod A. F. Concentration of -propanolol in isolated, perfused lungs of rat. Br. J. Pharmacol. 1976; 57: 67
   PubMed Web of Science ®Google Scholar
• Iwamoto K., Wtanabe J., Yonekawa H. Propranolol uptake with high capacity by rat perfused lung. J. Pharm. Pharmacol. 1988; 40: 445
   PubMedGoogle Scholar
• Heinzow B., Lüllmann H., Staib L. Uptake and displacement of [3H]-propranolol and [3H]-chlorpromazine in isolated, recirculating perfused guinea-pig lungs. Arch. Int. Pharmacodyn. Ther. 1988; 295: 211
   PubMedGoogle Scholar
• Howell R. E., Lanken P. N., Hansen Flaschen J. H., Haselton F. R., Albelda S. M., Fishman A. P. Pulmonary extraction of propranolol in normal and oxygen-toxic sheep. J. Pharmacol. Exp. Ther. 1989; 93: 250
   Google Scholar
• Yoshida H., Okumura K., Kamiya A., Hori R. Accumulation mechanism of basic drugs in the isolated perfused rat lung. Chem. Pharm. Bull. 1989; 37: 450
   PubMedGoogle Scholar
• Hori R., Okumura K., Yoshida H. Binding of basic drugs to rat lung mitochondria. Pharmaceutical Res. 1987; 4: 142
   PubMed Web of Science ®Google Scholar
• Lüllmann-Rauch R., Reil G. H. Chlor-phentermine-induced lipidosis-like ultrastructural alterations in lungs and adrenal glands of several species. Toxicol. Appl. Pharmacol. 1974; 30: 408
   PubMed Web of Science ®Google Scholar
• Angevine L. S., Mehendale H. M. Effect of chlorphentermine on the pulmonary disposition of 5-hydroxytryptamine in the isolated perfused rabbit lung. Am. Rev. Respir. Dis. 1980; 122: 891
   PubMed Web of Science ®Google Scholar
• Ohmiya Y., Angevine L. S., Mehendale H. M. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs. Drug Metab. Dispos. 1983; 11: 25
   PubMed Web of Science ®Google Scholar
• Mehendale H. M., Morita T., Angevine L. S. Effect of chlorphentermine on the pulmonary clearance of 5-hydroxytryptamine in rabbits in vivo. Pharmacology 1983; 26: 274
   PubMedGoogle Scholar
• Reasor M. J., Davis M. E. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital. Drug Metab. Dispos. 1985; 13: 192
   PubMed Web of Science ®Google Scholar
• Orton T. C., Anderson M. W., Pickett R. D., Eling T. E., Fouts J. R. Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs. J. Pharmacol. Exp. Ther. 1973; 186: 482
   PubMed Web of Science ®Google Scholar
• Minchin R. F., Boyd M. R. Uptake and metabolism of doxorubicin in isolated perfused rat lung. Biochem. Pharmacol. 1983; 32: 2829
   PubMed Web of Science ®Google Scholar
• Minchin R. F., Johnston M. R., Aiken M. A., Boyd M. R. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo. J. Pharmacol. Exp. Ther. 1984; 229: 193
   PubMedGoogle Scholar
• Bongard R. D., Roerig D. L., Johnston M. R., Linehan J. H., Dawson C. A. Influence of temperature and plasma protein on doxorubicin uptake by isolated lungs. Drug Metab. Dispos. 1993; 21: 428
   PubMedGoogle Scholar
• Muggia F. M., Louie A. C., Sikic B. I. Pulmonary toxicity of antitumor agents. Cancer Treat. Rev. 1983; 10: 221
   PubMedGoogle Scholar
• Camus P., Jeannin L. The diseased lung and drugs. Arch. Toxicol. 1984; 7(Suppl)66
   Google Scholar
• Kehrer J. P., Lee Y. C., Smith R. D. Effect of intratracheally administered anticancer drugs on lung hydroxyproline content. Toxicol. Lett. 1986; 30: 63
   PubMedGoogle Scholar
• Ryan U. S., Grantham C. J. Metabolism of endogenous and xenobiotic substances by pulmonary vascular endothelial cells. Pharmacol. Ther. 1989; 42: 235
   PubMedGoogle Scholar
• Gillis C. N. Pharmacological aspects of metabolic processes in the pulmonary microcirculation. Annu. Rev. Pharmacol. Toxicol. 1986; 26: 183
   PubMed Web of Science ®Google Scholar
• Bakhle Y. S. Pharmacokinetic and metabolic properties of lung. Br. J. Anaesthesiol. 1990; 65: 79
   PubMedGoogle Scholar
• Kutzman R. S., Popenoe E. A., Schmaeler M., Drew R. T. Changes in rat lung structure and composition as a result of subchronic exposure to acrolein. Toxicology 1985; 34: 139
   PubMed Web of Science ®Google Scholar
• Simionescu M., Simionescu N. Functions of the endothelial cell structure. Annu. Rev. Physiol. 1986; 48: 279
   PubMed Web of Science ®Google Scholar
• Cucinell S. A. Review of the toxicology of long-term phosgene exposure. Arch. Environ. Health 1974; 28: 272
   PubMed Web of Science ®Google Scholar
• Kennedy T. P., Michael J. R., Hoidal J. R., Hasty D., Sciuto A. M., Hopkins C., Lazar R., Bysani G. K., Tolley E., Gurtner G. H. Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene. J. Appl. Physiol. 1989; 67: 2542
   PubMed Web of Science ®Google Scholar
• Zanaboni P. B., Bradley J. D., Baudendistel L. J., Webster R. O., Dahms T. E. Cyclooxy genase inhibition prevents PMA-induced increases in lung vascular permeability. J. Appl. Physiol. 1990; 69: 1494
   PubMed Web of Science ®Google Scholar
• Gammal L. M., Wiley R. A., Traiger G., Haschek W. M., Baraban S. Toxicity-distribution relationships among 3-alkylfurans in the mouse lung. Toxicology 1984; 30: 177
   PubMed Web of Science ®Google Scholar
• IARC, International Agency for Research on Cancer. Benzo(a)pyrene. IARC Monographs of the Evaluation of the Carcinogenic Risk of the Chemicals to Humans. World Health Organization, International Agency for Research on Cancer. 1973; 3–91
   Google Scholar
• Hirai K. I., Yamauchi M., Witschi H., Coté M. G. Disintegration of lung peroxisomes during differentiation of type II cells to type I cells in buty-lated hydroxytoluene-administered mice. Exp. Mol. Pathol. 1983; 39: 129
   PubMedGoogle Scholar
• Coulombe P. A., Lassonde G., Coté M. G. Acute sensitivity of BHT-induced alveolar toxicity to a diquat challenge in murine lungs. Exp. Mol. Pathol. 1987; 47: 241
   PubMedGoogle Scholar
• Witschi H. R., Morse C. C. Enhancement of lung tumor formation in mice by dietary butylated hydroxytoluene: dose-time relationships and cell kinetics. J. Natl. Cancer Inst. 1983; 71: 859
   PubMed Web of Science ®Google Scholar
• Witschi H. P., Morse C. C. Cell kinetics in mouse lung following administration of carcinogens and butylated hydroxytoluene. Toxicol. Appl. Pharmacol. 1985; 78: 464
   PubMedGoogle Scholar
• Forkert P. G., Geddes B. A., Birch D. W., Massey T. E. Morphologic changes and covalent binding of 1,1-dichloroethylene in Clara and alveolar type II cells isolated from lungs of mice following in vivo administration. Drug Metab. Dispos. 1990; 18: 534
   PubMed Web of Science ®Google Scholar
• Boyd M. R. Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. Crit. Rev. Toxicol. 1980; 7: 103
   PubMed Web of Science ®Google Scholar
• Christian M. C., Wittes R. E., Leyland-Jones B., McLemore T. L., Smith A. C., Grieshaber C. K., Chabner B. A., Boyd M. R. 4-Ipomeanol: a novel investigational new drug for lung cancer. J. Natl. Cancer Inst. 1989; 81: 1133
   PubMedGoogle Scholar
• Ruangyuttikarn W., Appleton M. L., Yost G. S. Metabolism of 3-methylindole in human tissues. Drug Metab. Dispos. 1991; 19: 977
   PubMed Web of Science ®Google Scholar
• Thornton-Manning J. R., Nichols W. K., Manning B. W., Skiles G. S., Yost G. S. Metabolism and bioactivation of 3-methylindole by Clara cells, alveolar macrophages, and subcellular fractions from rabbit lungs. Toxicol. Appl. Pharmacol. 1993; 122: 182
   PubMed Web of Science ®Google Scholar
• Nocerini M. R., Carlson J. R., Yost G. S. Adducts of 3-methylindole and glutathione: species differences in organ-selective bioactivation. Toxicol. Lett. 1985; 28: 79
   PubMed Web of Science ®Google Scholar
• Woods L. W., Wilson D. W., Schiedt M. J., Giri S. N. Structural and biochemical changes in lungs of 3-methylindole-treated rats. Am. J. Pathol. 1993; 142: 129
   PubMedGoogle Scholar
• Hoffmann D., Rivenson A., Amin S., Hecht S. S. Dose-response study of the carcinogenicity of tobacco-specificN-nitrosamines in F344 rats. J. Cancer Res. Clin. Oncol. 1984; 108: 81
   PubMed Web of Science ®Google Scholar
• Rivenson A., Hoffmann D., Prokopczyk B., Amin S., Hecht S. S. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and areca-derivedN-nitrosamines. Cancer Res. 1988; 48: 6912
   PubMed Web of Science ®Google Scholar
• Lin J. M., Desai D. H., Morse M. A., Amin S., Hecht S. S. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone pulmonary metabolism and tumorigenicity in mice by analogues of the investigational chemotherapeutic drug 4-ipomeanol. Chem. Res. Toxicol. 1992; 5: 674
   PubMedGoogle Scholar
• Preston-Martin S. Evaluation of the evidence that tobacco-specific nitrosamines (TSNA) cause cancer in humans. Crit. Rev. Toxicol. 1991; 21: 295
   PubMed Web of Science ®Google Scholar
• Jorquera R., Castonguay A., Schuller H. M. Placental transfer of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone instilled intratracheally in Syrian golden hamsters. Cancer Res. 1992; 52: 3273
   PubMed Web of Science ®Google Scholar
• Cashman J. R., Traiger G. J., Hanzlik R. P. Pneumotoxic effects of thiobenzamide derivatives. Toxicology 1982; 23: 85
   PubMedGoogle Scholar
• Penney D. A., Gottschall D. W., Hanzlik R. P., Traiger G. J. The role of metabolism inN-methylthiobenzamide-induced pneumotoxicity. Toxicol. Appl. Pharmacol. 1985; 78: 323
   PubMedGoogle Scholar
• Lafranconi W. M., Huxtable R. J. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Biochem. Pharmacol. 1984; 33: 2479
   PubMed Web of Science ®Google Scholar
• Sugita T., Stenmark K. R., Wagner W. W., Jr., Henson P. M., Henson J. E., Hyers T. M., Reeves J. T. Abnormal alveolar cells in monocrotaline induced pulmonary hypertension. Exp. Lung Res. 1983; 5: 201
   PubMed Web of Science ®Google Scholar
• Ghodsi F., Will J. A. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am. J. Physiol. 1981; 24: H149
   Google Scholar
• Hardwick S. J., Skamarauskas J. T., Smith L. L., Upshall D. G., Cohen G. M. Protection of rats against the effects of alpha-naphthylthiourea (ANTU) by elevation of non-protein sulfydryl levels. Biochem. Pharmacol. 1991; 42: 1203
   PubMedGoogle Scholar
• Cunningham A. L., Hurley J. V. Alpha-naphthylthiourea-induced pulmonary oedema in the rat: a topographical and electron-microscope study. J. Pathol. 1972; 106: 25
   PubMed Web of Science ®Google Scholar
• Honda T., Kiyozumi M., Kojima S. Alkylnaphthalene. XI. Pulmonary toxicity of naphthalene, 2-methylnaphthalene, and isopropylnaph-thalenes in mice. Chem. Pharm. Bull. 1990; 38: 3130
   PubMed Web of Science ®Google Scholar
• Verschoyle R. D., Carthew P., Wolf C. R., Dinsdale D. 1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity. Toxicol. Appl. Pharmacol. 1993; 122: 208
   PubMed Web of Science ®Google Scholar
• Reid W., Ilett K., Glick J., Krishna G. Metabolism and binding of aromatic hydrocarbons in the lung. Relationship to experimental bronchiolar necrosis. Am. Rev. Respir. Dis. 1973; 107: 539
   PubMed Web of Science ®Google Scholar
• Smith L. L. Paraquat toxicity. Philos. Trans. R. Soc. Lond. Biol. 1985; 311: 647
   PubMed Web of Science ®Google Scholar
• Smith L. L. The response of the lung to foreign compounds that produce free radicals. Annu. Rev. Physiol. 1986; 48: 681
   PubMedGoogle Scholar
• Odum J., Foster J. R., Green T. A mechanism for the development of clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem. Biol. Intract. 1992; 83: 135
   PubMed Web of Science ®Google Scholar
• Kehrer J. P., Klein Szanto A. J., Thurston D. E., Lindenschmidt R. C., Witschi H. R. O,S,S,-trimethyl phosphorodithioate-induced lung damage in rats and mice. Toxicol. Appl. Pharmacol. 1986; 84: 480
   PubMedGoogle Scholar
• Verschoyle R. D., Cabral J. R. P. Investigation of the acute toxicity of some trimethyl and triethyl phosphorothioates with particular reference to those causing lung damage. Arch. Toxicol. 1982; 51: 221
   Web of Science ®Google Scholar
• Dinsdale D., Verschoyle R. D., Ingham J. E. Ultrastructural changes in rat clara cells induced by a single dose ofO,S,S-trimethyl phosphorodithioate. Arch. Toxicol. 1984; 56: 59
   PubMed Web of Science ®Google Scholar
• Durham S. K., Mezza L. E., Imamura T. Pulmonary endothelial and alveolar epithelial lesions induced byO,O,S,-trimethyl phosphorothioate in rats. J. Pathol. 1988; 155: 247
   PubMedGoogle Scholar
• Witschi H., Godfrey G., Frome E., Lindenschmidt R. C. Pulmonary toxicity of cytostatic drugs: cell kinetics. Fundam. Appl. Toxicol. 1987; 8: 253
   PubMedGoogle Scholar
• Rosenow E. C. The spectrum of drug-induced pulmonary disease. Ann. Intern. Med. 1972; 77: 977
   PubMed Web of Science ®Google Scholar
• Podoll L. N., Winkler S. S. Busulfan lung. Am. J. Roent. Rad. Ther. Nucl. Med. 1974; 120: 151
   PubMedGoogle Scholar
• Cannon G. W. Pulmonary complications of antirheumatic drug therapy. Semin. Arthritis Rheum. 1990; 19: 353
   PubMedGoogle Scholar
• Bailey C. C., Marsden H. B., Jones P. H. Fatal pulmonary fibrosis following 1,3-bis(z-chloroethyl)-1-itrosourea (BCNU) therapy. Cancer 1978; 42: 74
   PubMed Web of Science ®Google Scholar
• Durant J. R., Norgard M. J., Murad T. M., Bartolucci A. A. Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU). Ann. Intern. Med. 1979; 90: 191
   PubMed Web of Science ®Google Scholar
• Goucher G., Rowland V., Hawkins J. Melphalan-induced pulmonary interstitial fibrosis. Chest 1980; 77: 805
   PubMedGoogle Scholar
• Schallier D., Impens N., Warson F., VanBeUe S., De Wasch G. Additive pulmonary toxicity with melphalan and busulfan therapy. Chest 1983; 84: 492
   PubMedGoogle Scholar
• Trask C. W. L., Joannides T., Harper P. G., Tobias J. G., Spiro S. G., Geddes D. M., Souhami R. L., Beverly P. C. Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high dose cyclophosphamide. Cancer 1985; 55: 57
   PubMed Web of Science ®Google Scholar
• Smith R. D., Kehrer J. P. Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity. Cancer Res. 1991; 51: 542
   PubMed Web of Science ®Google Scholar
• Garbes I. D., Henderson E. S., Gomez G. A., Bakshi S. P., Parthasarathy K. L., Castillo N. B. Procarbazine-induced interstitial pneumonitis with a normal chest X-ray: a case report. Med. Pediatr. Oncol. 1986; 14: 238
   PubMedGoogle Scholar
• Lewis L. D. Procarbazine associated alveolitis. Thorax 1984; 39: 206
   PubMedGoogle Scholar
• Trush M. A, Mimnaugh E. G. Toxicologic implications of the iron-dependent activation of bleomycin A2 by mouse lung microsomes. Adv. Exp. Med. Biol. 1986; 197: 291
   PubMedGoogle Scholar
• Giri S. N., Chen Z. L., Younker W. R., Schiedt M. J. Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamsters. Toxicol. Appl. Pharmacol. 1983; 71: 132
   PubMed Web of Science ®Google Scholar
• Hollinger M. A., Giri S. N. The effect of bleomycin on the uptake and incorporation of [14C]choline into phospholipids in hamster lung tissue slices. Lipids 1990; 25: 863
   PubMed Web of Science ®Google Scholar
• Camus P., Coudert B., D'Athis P., Foucher P., Delchambre J., Dupront A., Jeannin L. Pharmacokinetics and metabolism of nilutamide in the isolated rat lung. J. Pharmacol Exp. Ther. 1991; 259: 1247
   PubMedGoogle Scholar
• Krowka M. J., Breuer R. I., Kehoe T. J. Azathioprine-associated pulmonary dysfunction. Chest 1983; 4: 696
   Google Scholar
• Wilson B. D., Jaworski A. J., Donner M. E., Lippmann M. L. Amiodarone-induced pulmonary toxicity in the rat. Lung 1989; 167: 301
   PubMed Web of Science ®Google Scholar
• Martin W. J. Mechanisms of amiodarone pulmonary toxicity. Clinics Chest Med. 1990; 11: 131
   PubMedGoogle Scholar
• Daniels J. M., Brien J. F., Massey T. E. Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone. Toxicol. Appl Pharmacol. 1989; 100: 350
   PubMed Web of Science ®Google Scholar
• Stephenson A. H., Sprague R. S., Dahms T. E., Lonigro A. J. Unilateral acute lung injury induced by ethchlorvynol in anesthetized dogs. J. Appl. Physiol. 1984; 56: 1252
   PubMedGoogle Scholar
• Fischer P., Glauser F. L., Millen J. E., Lewis J., Egan P. The effect of ethchlorvynol on pulmonary alveolar membrane permeability. Am. Rev. Respir. Dis. 1977; 116: 901
   PubMed Web of Science ®Google Scholar
• Zanaboni P. B., Bradley J. D., Webster R. O., Dahms T. E. Cyclooxygenase inhibitors prevent ethchlorvynol-induced injury in rat and rabbit lungs. J. Appl. Physiol. 1991; 71: 43
   PubMedGoogle Scholar
• Fringes B., Gorgas K., Reith A. Clofibrate increases the number of peroxisomes and of lamellar bodies in alveolar cells type II of the rat lung. Eur. J. Cell. Biol. 1988; 46: 136
   PubMedGoogle Scholar
• Fringes B., Gorgas K., Reith A. Modification of surfactant metabolizing cells in rat lung by clofibrate, a hypolipidemic peroxisome proliferating agent. Virchows Arch. B. Cell. Pathol. 1988; 54: 232
   Google Scholar
• Martin W. J., Powis G. W., Kachel D. L. Nitrofurantoin-stimulated oxidant production in pulmonary endothelial cells. J. Lab. Clin. Med. 1985; 105: 23
   PubMedGoogle Scholar
• Suntres Z. E., Shek P. N. Nitrofurantoin-induced pulmonary toxicity. In vivo evidence for oxidative stress-mediated mechanisms. Biochem. Pharmacol. 1992; 43: 1127
   PubMed Web of Science ®Google Scholar
• Ryan J. W. Processing of endogenous polypeptides by the lung. Annu. Rev. Physiol. 1982; 44: 241
   PubMed Web of Science ®Google Scholar
• Westcott J. Y., Henson J., McMurtry I. V., O'Brien R. F. Uptake and metabolism of endothelin in the isolated perfused rat lung. Exp. Lung Res. 1990; 16: 521
   PubMed Web of Science ®Google Scholar
• McManus L. M., Deavers S. I. Platelet activating factor in pulmonary pathobiology. Clinics Chest Med. 1989; 10: 107
   PubMed Web of Science ®Google Scholar
• Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373
   PubMed Web of Science ®Google Scholar
• Stewart A. G., Thompson J. S., Rogers T. K., Morice A. H. Atrial natriuretic peptide-induced relaxation of preconstricted isolated rat perfused lungs: a comparison in control and hypoxia-adapted animals. Clin. Sci. 1991; 81: 201
   Google Scholar
• Broquet P., Tonqui L., Shen T. Y., Vargafting B. B. Perspectives in platelet activating factor research. Pharmacol. Rev. 1987; 39: 97
   PubMedGoogle Scholar
• Vanhoutte P. M., Rubanyi E. M., Miller V. M., Houston D. S. Modulation of vascular smooth muscle contraction by the endothelium. Annu. Rev. Physiol. 1986; 48: 307
   PubMed Web of Science ®Google Scholar
• Bernhard W., Bothe Sandtfort E., Koop H., Cassel W., von Wichert P. Degradation of vasoactive intestinal peptide by isolated, ventilated, and perfused rat lungs. Eur. J. Clin. Invest. 1989; 19: 506
   PubMed Web of Science ®Google Scholar
• Das D. K., Steinberg H. Specific binding of serotonin in rat lung. Am. J. Physiol. 1985; 248: E58
   Google Scholar
• Dawson C. A., Bongard R. D., Rickaby D. A., Linehan J. H., Roerig D. L. Effect of transit time on metabolism of a pulmonary endothelial enzyme substrate. Am. J. Physiol. 1989; 257: H853
   Google Scholar
• Linehan J. H., Bongard R. D., Roerig D. L., Bronikowski T. A., Dawson C. A. Lung angiotensin-converting enzyme kinetics from indicator-dilution and constant-infusion methods. Am. J. Physiol. 1990; 258: H436
   Google Scholar
• Howell R. E., Moalli R. Analysis of rabbit pulmonary angiotensin converting enzyme kinetics in vivo. J. Pharmacol. Exp. Ther. 1983; 228: 154
   Google Scholar
• Mor L., Bomzon A., Frenkel R., Joudim M. B. H. Angiotensin-converting enzyme activity in the isolated perfused guinea pig lung. J. Pharmacol. Meth. 1990; 23: 141
   PubMedGoogle Scholar
• Sato H., Terasaki T., Tsuji A. Specific binding and clearance of [3H]dynorphin (1–13) in the perfused rat lung: an application of the multipleindicator dilution method. J. Pharm. Pharmacol. 1990; 42: 879
   PubMedGoogle Scholar
• Said S. I. Pulmonary metabolism of prostaglandins and vasoactive peptides. Annu. Rev. Physiol. 1982; 44: 257
   PubMed Web of Science ®Google Scholar
• Bakhle Y. S., Ferreira S. H. Lung metabolism of eicosanoids: prostaglandins, prostacyclin, thromboxane, and leukotrienes. Handbook of Physiology: The Respiratory System. American Physiological Society, Bethesda, MD 1985; Vol. 1: 365
   Google Scholar
• Lewis C. P. L., Cohen G. M., Smith L. L. The identification and characterization of an uptake system for taurine into rat lung slices. Biochem. Pharmacol. 1990; 39: 431
   PubMedGoogle Scholar
• Lin Y. J., Schanker L. S. Pulmonary absorption and lung slice uptake of a foreign amino acid — species comparison. Drug Metab. Dispos. 1983; 11: 75
   PubMedGoogle Scholar
• Dawson C. A., Linehan J. H., Rickaby D. A., Roerig D. L. Influence of plasma protein on the inhibitory effects of indocyanine green and bromcresol green on pulmonary prostaglandin El extraction. Br. J. Pharmacol. 1984; 81: 449
   PubMedGoogle Scholar
• Pitt B. R., Forder J. R., Gillis C. N. Drug-induced impairment of pulmonary [3H]prostaglandin El removal in vivo. J. Pharmacol. Exp. Ther. 1983; 227: 531
   PubMedGoogle Scholar
• Cox J. W., Andreadis N. A., Bone R. C., Maunder R. J., Pullen R. H., Ursprung J. J., Vassar M. J. Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1988; 137: 5
   PubMedGoogle Scholar
• Hammond G. L., Cronau L. H., Whittaker D., Gillis C. N. Fate of prostaglandins El and Al in the human pulmonary circulation. Surgery 1977; 81: 716
   PubMed Web of Science ®Google Scholar
• Ferreira S. H., Vane J. R. Prostaglandins: their disappearance from and release into the circulation. Nature 1967; 216: 868
   PubMed Web of Science ®Google Scholar
• Bito L. Z., Baroody R. A., Reitz M. E. Dependence of pulmonary prostaglandin metabolism on carrier-mediated transport processes. Am. J. Physiol. 1977; 232: E382
   Google Scholar
• Eling T. E., Ally A. I. Pulmonary biosynthesis and metabolism of prostaglandins and related substances. Environ. Health Perspect. 1984; 55: 159
   PubMed Web of Science ®Google Scholar
• Cohen G. M. Metabolic basis of target organ toxicity. Biological Basis of Detoxication, J. Caldwell, W. B. Jakoby. Academic Press, New York 1983; 325
   Google Scholar
• Catravas J. D., Gillis C. N. Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: kinetics and sites of removal. J. Pharmacol. Exp. Ther. 1983; 224: 28
   PubMedGoogle Scholar
• Minchin R. F., Baraber H. E., Ilett K. F. Effect of prolonged desmethylimipramine administration on the pulmonary clearance of 5-hydrox-ytryptamine and β-phenylethylamine in rats. Drug Metab. Dispos. 1982; 10: 356
   PubMedGoogle Scholar
• Peeters F. A., Bronikowski T. A., Dawson C. A., Linehan J. H., Bult H., Herman A. G. Kinetics of serotonin uptake in isolated rabbit lungs. J. Appl. Physiol. 1989; 66: 2328
   PubMedGoogle Scholar
• Bryan-Lluka L. J., O'Donnell S. R. Isolated perfused lungs of guinea-pig, in contrast with rat, lack an uptake process for noradrenaline. Pulmon. Pharmacol. 1991; 4: 146
   PubMedGoogle Scholar
• Gillis C. N., Cronau L. H., Mandel S., Hammond G. L. Indicator dilution measurement of 5-hydroxytryptamine clearance by human lung. J. Appl. Physiol. 1979; 46: 1178
   PubMed Web of Science ®Google Scholar
• Ben-Harari R. R., Youdim M. B. H. Ontogenesis of uptake and deamination of 5-hydroxytryptamine, dopamine and β-phenylethylamine in isolated perfused lung and lung homogenates from rats. Br. J. Pharmacol. 1981; 72: 731
   PubMed Web of Science ®Google Scholar
• Cardoso P. F., Spino M., Mayer E., Shi S. Q., Pop R. D., Puskas J., Perrier D., Tong J., Baines A. D., Patterson G. A. Use of an isolated in situ canine lung perfusion model to evaluate dopamine clearance by the lung. J. Pharmacol. Exp. Ther. 1991; 259: 1271
   PubMedGoogle Scholar
• Dawson C. A., Christensen C. W., Rickaby D. A., Linehan J. H., Johnston M. R. Lung damage and pulmonary uptake of serotonin in intact dogs. J. Appl. Physiol. 1985; 58: 1761
   PubMedGoogle Scholar
• Junod A. F. 5-Hydroxytryptamine and other amines in the lung. Handbook of Physiology: The Respiratory System. American Physiological Society, Bethesda, MD 1985; Vol. 1: 337
   Google Scholar
• Boileau J. C., Campeau L., Biron P. Pulmonary fate of histamine, isoproterenol, physoalaemine and substance P. Can. J. Physiol. Pharmacol. 1970; 48: 681
   PubMedGoogle Scholar
• Gillis C. N., Pitt B. R. The fate of circulating amines within the pulmonary circulation. Annu. Rev. Physiol. 1982; 44: 269
   PubMed Web of Science ®Google Scholar
• Bryan-Lluka L. J., O'Donnell S. R. Dopamine and adrenaline, but not isoprenaline, are substrates for uptake and metabolism in isolated perfused lungs of rats. Naunyn-Schmiedesberg Arch. Pharmacol. 1992; 346: 20
   PubMedGoogle Scholar
• Rickaby D. A., Dawson C. A., Linehan J. H. Influence of embolism and imipramine on kinetics of serotonin uptake by dog lung. J. Appl. Physiol. 1984; 56: 1170
   PubMedGoogle Scholar
• Olson E. B., Jr., De Wolf R. E., Rankin J. Uptake of metabolism of norepinephrine in isolated perfused fetal, newborn and adult rabbit lungs. Life Sci. 1983; 32: 321
   PubMedGoogle Scholar
• Rao S. B., Mehendale H. M. Uptake and disposition of putrescine, spermidine, and spermine by rabbit lungs. Drug Metab. Dispos. 1987; 15: 189
   PubMedGoogle Scholar
• Wyatt I., Soames A. R., Clay M. F., Smith L. L. The accumulation and localisation of putrescine, spermidine, spermine and paraquat in the rat lung. In vitro and in vivo studies. Biochem. Pharmacol. 1988; 37: 1909
   PubMed Web of Science ®Google Scholar
• Rannels D. E., Addison J. L., Pegg A. E. Carrier-mediated uptake of methylglyoxal bis(guanylhydrazone) by rat lungs perfused in situ. Am. J. Physiol. 1985; 248: E292
   PubMed Web of Science ®Google Scholar
• Sokol P. P., Longenecker K. L., Kachel D. L., Martin W. J. II, Mechanisms of putrescine transport in human pulmonary artery endothelial cells. J. Pharmacol. Exp. Ther. 1993; 265: 60
   PubMedGoogle Scholar
• Toninello A., Via L. D., Siliprandi D., Garlid K. D. Evidence the spermine, spermidine, and putrescine are transported electrophoretically in mitochondria by a specific polyamine uniporter. J. Biol. Chem. 1992; 267(18)393
   Google Scholar
• Siliprandi D., Toninello A., Via L. D. Bidirectional transport of spermine in rat liver mitochondria. Biochim. Biophys. Acta 1992; 1102: 62
   PubMedGoogle Scholar
• Shiao R. T., Kostenbauder H. B., Olson J. W., Gillespie M. N. Mechanisms of lung polyamine accumulation in chronic hypoxic pulmonary hypertension. Am. J. Physiol. 1990; 259: L351
   Google Scholar
• Atkinson J. E., Olson J. W., Altiere R. J., Gillespie M. N. Evidence that hypoxic pulmonary vascular remodeling in rats is polyamine dependent. J. Appl. Physiol. 1987; 62: 1562
   PubMed Web of Science ®Google Scholar
• Olson J. W., Atkinson J. E., Hacker A. D., Altiere R. J., Gillespie M. N. Suppression of polyamine biosynthesis prevents monocrotaline-induced pulmonary edema and arterial medial thickening. Toxicol. Appl. Pharmacol. 1985; 81: 91
   PubMed Web of Science ®Google Scholar
• Moulinoux J. Ph., Quemener V., Khan N. A. Biological significance of circulating polyamines in oncology. Cell. Mol. Biol. 1991; 37: 773
   PubMed Web of Science ®Google Scholar
• Brigelius R., Dostal L. A., Horton J. K., Bend J. R. Alteration of the redox state of NADPH and glutathione in perfused rabbit lung by paraquat. Toxicol Ind. Health 1986; 2: 417
   PubMedGoogle Scholar
• Bus J. S., Gibson J. E. Paraquat: model for oxidant-initiated toxicity. Environ. Health Perspect. 1984; 55: 37
   PubMed Web of Science ®Google Scholar
• Pitt B. R., Hadden P., Gillis C. N. In-line assessment of pulmonary extraction of 125I-metaiodo-benzylguamdine (MIBG) by perfused rabbit lung. Fed. Proc. 1987; 46: 665
   Google Scholar
• Slosman D. O., Morel D. R., Mo Costabella P. M., Donath A. Lung uptake of 131I-metaiodo-benzylguanidine in sheep. An in vivo measurement of pulmonary metabolic function. Eur. J. Nucl. Med. 1988; 14: 65
   PubMedGoogle Scholar
• Ben-Harari R. R., Bakhle Y. S. Uptake of β-phenylethylamine in rat isolated lung. Biochem. Pharmacol. 1980; 29: 489
   PubMed Web of Science ®Google Scholar
• Angevine L. S., Lockard V. G., Mehendale H. M. Effect of chlorphentermine pretreatment on the distribution of chlorphentermine in isolated perfused rat lungs. Fundam. Appl. Toxicol. 1984; 4: 202
   PubMedGoogle Scholar
• Reasor M. J. Influence of pre-existing phospholipidosis on the accumulation of amiodarone and desethyla-miodarone in rat alveolar macrophages. Res. Commun. Chem. Pathol. Pharmacol. 1991; 72: 169
   PubMedGoogle Scholar
• Camus P., Coudert B., D'Athis P., Dumas M., Escousse A., Jeannin L. Pharmacokinetics of amiodarone in the isolated rat lung. J. Pharmacol. Exp. Ther. 1990; 254: 336
   PubMedGoogle Scholar
• Reasor M. J., Ogle C. L., Kacew S. Amiodarone-induced pulmonary toxicity in rats: biochemical and pharmacological characteristics. Toxicol. Appl. Pharmacol. 1989; 97: 124
   PubMed Web of Science ®Google Scholar
• Camus P., Mehendale H. M. Pulmonary sequestration of amiodarone and desethylamiodarone. J. Pharmacol. Exp. Ther. 1986; 237: 867
   PubMedGoogle Scholar
• Brien J. F., Jimmo S., Brennan F. J., Ford S. E., Armstrong P. W. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can. J. Physiol. Pharmacol. 1987; 65: 360
   PubMed Web of Science ®Google Scholar
• Kannan R., Sarma J. S., Guha M., Venkataraman K. Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats. Fundam. Appl. Toxicol. 1991; 16: 103
   PubMedGoogle Scholar
• Antonini J. M., Reasor M. J. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem. Pharmacol. 1991; 42(Suppl)S151
   Google Scholar
• Junod A. F. Accumulation of 14C-Imipramine in isolated perfused rat lungs. J. Pharmacol. Exp. Ther. 1972; 183: 182
   PubMed Web of Science ®Google Scholar
• Lewis R. W., Harwood J. L., Richards R. J. Metabolic effects on the lung, liver and brain following ingestion of imipramine and chlorpromazine by the rat. Drug Chem. Toxicol. 1983; 6: 135
   PubMed Web of Science ®Google Scholar
• Paci A., Ciarimboli G., Miniati M., Cocci F., Piras F., Pistolesi M. Lung tissue binding of iodobenzyl-propanediamine: involvement of beta-adrenergic receptors. J. Pharm. Biomed. Anal. 1989; 7: 1467
   PubMedGoogle Scholar
• Yoshida H., Okumura K., Hori R. Subcellular distribution of basic drugs accumulated in the isolated perfused lung. Pharm. Res. 1987; 4: 50
   PubMedGoogle Scholar
• Okumura K., Yoshida H., Kamiya A., Hori R. Submitochondrial distribution of basic drugs in the isolated perfused lung. Chem. Pharm. Bull. Tokyo 1989; 37: 1109
   PubMedGoogle Scholar
• Yoshida H., Okumura K., Hori R. Contribution of monoamine oxidase (MAO) to the binding of tertiary basic drugs in isolated perfused rat lung. Pharm. Res. 1990; 7: 398
   PubMedGoogle Scholar
• Iwamoto K., Watanabe J., Yonekawa H. Effect of age on the uptake of propranolol by perfused rat lung. Biochem. Pharmacol. 1988; 37: 4029
   PubMedGoogle Scholar
• Covino B. G. Pharmacology of local anaesthetic agents. Br. J. Anaesthesiol. 1986; 58: 701
   PubMed Web of Science ®Google Scholar
• Tucker G. T. Pharmacokinetics of local anaesthetics. Br. J. Anaesthesiol. 1986; 58: 717
   PubMed Web of Science ®Google Scholar
• Burm A. G. L. Clinical pharmacokinetics of epidural and spinal anaesthesia. Clin. Pharmacokin. 1989; 16: 283
   PubMedGoogle Scholar
• Rothstein P., Cole J. S., Pitt B. R. Pulmonary extraction of [3H]bupivacaine: modification by dose, propranolol and interaction with [14C]5-hydrox-ytryptamine. J. Pharmacol. Toxicol. Exp. Ther. 1986; 240: 410
   Google Scholar
• Palazzo M. G., Kalso E. A., Argiras E., Madgwick R., Sear J. W. First pass lung uptake of bupivacaine: effect of acidosis in an intact rabbit lung model. Br. J. Anaesthesiol. 1991; 67: 759
   PubMedGoogle Scholar
• Palazzo M. G., Kalso E., Argiras E., Madgwick R., Sear J. The uptake of bupivacaine in an in situ isolated perfused rabbit lung preparation. Pliarmacol. Toxicol. 1991; 69: 107
   PubMedGoogle Scholar
• Foth H., Geng W. P., Krug N., Vetterlein F. Pulmonary uptake of bupivacaine by isolated perfused rat lung. Naunyn-Schmiedeberg Arch. Pharmacol. 1995; 351: 99
   PubMedGoogle Scholar
• Keitzmann D., Foth H., Geng W. P., Rathgeber J., Gundert-Remy U., Kettler D. Trans-pulmonary disposition of prilocaine, mepivaine, bupivacaine in humans in the course of epidural anaesthesia. Acta Anaesthesiol. Scand. 1995; 39, in press
   Google Scholar
• Ruggere M. D., Patel Y. C. Somatostatin metabolism by the isolated rat lung. Endocrinology 1985; 117: 1870
   PubMedGoogle Scholar
• Hollister A. S., Rodeheffer R. J., White F. J., Potts J. R., Imada T., Inagami T. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J. Clin. Invest. 1989; 83: 623
   PubMed Web of Science ®Google Scholar
• Manwaring D., Mullane K. Disappearance of enkephalins in the isolated perfused rat lung. Life Sci. 1984; 35: 1787
   PubMed Web of Science ®Google Scholar
• Ben Harari R. R., Parent Ermini A., Kleinerman J. Metabolism of 5-hydroxytryptophan in the isolated perfused rat lung. Pharmacology 1990; 41: 272
   PubMedGoogle Scholar
• McGiff J. C., Terragno N. A., Strand J. C., Lee J. B., Lonigro A. J., Ng K. K. F. Selective passage of prostaglandins across the lung. Nature 1969; 223: 743
   Google Scholar
• Rao S. B., Mehendale H. M. Comparative evaluation of sequestration of polyamines by perfused rabbit and rat lungs. Indian J. Exp. Biol. 1990; 28: 1166
   PubMedGoogle Scholar
• Bachmann M. B., Biscoping J., Adams H. D., Menges T., Krumholz W., Hempelmann G. Die Bedeutung des Entnahmeortes bei der Bestimmung von Lokalanaesthetikakonzentrationen im Plasma am Beispiel von Bupivacain 0.75%. Regional-Anaesthesie 1990; 13: 16
   PubMedGoogle Scholar
• Soucek P., Gut I. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica 1992; 22: 83
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J. Human cytochromes P-450: problems and prospects. TiPS 1992; 13: 346
   PubMed Web of Science ®Google Scholar
• Wheeler C. W., Guenthner T. M. Cytochrome P-450-dependent metabolism of xenobiotics in human lung. J. Biochem. Toxicol. 1991; 6: 163
   PubMedGoogle Scholar
• Penning T. M., Sharp R. B. Characterization of dihydrodiol dehydrogenase in human liver and lung. Carcinogenesis 1990; 11: 1203
   PubMedGoogle Scholar
• Schladt L., Worner W., Setiabudi F., Oesch F. Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats. Biochem. Pharmacol. 1986; 35: 3309
   PubMed Web of Science ®Google Scholar
• De Pierre J. W., Siedegard J., Morgenstern R., Balk L., Meijer J., Astrom A., Norelius I., Ernster L. Induction of cytosolic glutathione transferase and microsomal epoxide hydrolase activities in extrahepatic organs of the rat by phenobarbital, 3-methylcholanthrene and trans-stilbene oxide. Xenobiotica 1984; 14: 295
   PubMed Web of Science ®Google Scholar
• Devereux T. R., Domin B. A., Philpot R. M. Xenobiotic metabolism by isolated pulmonary cells. Pharmacol. Ther. 1989; 41: 243
   PubMed Web of Science ®Google Scholar
• Devereux T. R., Massey T. E., Van Scott M. R., Yankaskas J., Fouts J. R. Xenobiotic metabolism in human alveolar type II cells isolated by centrifugal elutriation and density gradient centrifuga-tion. Cancer Res. 1986; 46: 5438
   PubMedGoogle Scholar
• Pacifici G. M., Franchi M., Bencini C., Repetti F., Di Lascio N., Muraro G. B. Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 1988; 18: 849
   PubMed Web of Science ®Google Scholar
• Chichester C. H., Philpot R. M., Weir A. J., Buckpitt A. R., Plopper C. G. Characterization of the cytochrome P-450 monooxygenase system in nonciliated bronchiolar epithelial (Clara) cells isolated from mouse lung. Am. J. Respir. Cell. Mol. Biol. 1991; 4: 179
   PubMed Web of Science ®Google Scholar
• Lorenz J., Glatt H. R., Fleischmann R., Ferlinz R., Oesch F. Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in subcellular fractions of lung and liver. Biochem. Med. 1984; 32: 43
   PubMedGoogle Scholar
• Antilla S., Vainio H., Hietanen E., Camus A. M., Mala veille C., Brun G., Husgafvel-Pursiainen K., Haikkila L., Karjalainen A., Bartsch H. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients. Environ. Health Perspect. 1992; 98: 179
   PubMedGoogle Scholar
• Toussaint C., Albin N., Massaad L., Grunenwald D., Parise O., Jr., Morizet J., Gouyette A., Chabot G. G. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Res. 1993; 53: 4608
   PubMed Web of Science ®Google Scholar
• De Waziers I., Cugnenc P. H., Yang C. S., Leroux J. P., Beaune P. H. Cytochrome P-450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 1990; 253: 387
   PubMed Web of Science ®Google Scholar
• Omiecinski C. L. Tissue-specific expression of rat mRNAs homologous to cytochromes P-450b and P-450e. Nucleic Acids Res. 1986; 14: 1525
   PubMed Web of Science ®Google Scholar
• Friedberg T., Siegert P., Grassow M. A., Bartlomowicz B., Oesch F. Studies of the expression of the cytochrome P-450 IA, P-450 IIB, and P-450 IIC gene family in extrahepatic and hepatic tissues. Environ. Health Perspect. 1990; 88: 67
   PubMed Web of Science ®Google Scholar
• Wolf C. R., Smith B. R., Ball L. M., Serabjit-Singh C., Bend J. R., Philpot R. M. The rabbit pulmonary monooxygenase system. Catalytic differences between two purified forms of cytochrome P-450 in the metabolism of benzo(a)pyrene. J. Biol. Chem. 1979; 254: 3658
   PubMed Web of Science ®Google Scholar
• Godden P. M., Kass G., Mayer R. T., Burke M. D. The effects of cigarette smoke compared to 3-methyl-cholanthrene and phenobarbitone on alkoxyresorufin metabolism by lung and liver microsomes from rats. Biochem. Pharmacol. 1987; 36: 3393
   PubMed Web of Science ®Google Scholar
• Serabjit-Singh C. J., Albro P. W., Robertson I. G., Philpot R. M. Interactions between xenobiotics that increase or decrease the levels of cytochrome P-450 isozymes in rabbit lung and liver. J. Biol. Chem. 1983; 258(12)827
   Google Scholar
• Sesardic D., Cole K. J., Edwards R. J., Davies D. S., Thomas P. E., Levin W., Boobis A. R. The inducibility and catalytic activity of cytochromes P-450c (P-450IA1) and P-450d (P-450IA2) in rat tissues. Biochem. Pharmacol. 1990; 39: 499
   PubMed Web of Science ®Google Scholar
• Shimada T., Yun C. H., Yamazaki H., Gautier J. C., Beaune P. H., Guengerich F. P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 1992; 41: 856
   PubMed Web of Science ®Google Scholar
• McLemore T. L., Adelberg S., Liu M. C., Mc Mahon N. A., Yu S. J., Hubbard W. C., Czerwinski M., Wood T. G., Storeng R., Lubet R. A., Eggleston J. C., Boyd M. R., Hines R. N. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst. 1990; 82: 1333
   PubMed Web of Science ®Google Scholar
• Wheeler C. W., Guenthner T. M. Cytochrome P-450-dependent metabolism of xenobiotics in human lung. J. Biochem. Toxicol. 1991; 6: 163
   PubMedGoogle Scholar
• Welch R. M., Harrison Y. E., Conney A. H. Cigarette smoking: stimulatory effect on metabolism of 3,4-benzopyrene by enzymes in human placenta. Science 1968; 160: 541
   PubMed Web of Science ®Google Scholar
• Bilimoria M. H., Johnson J., Hogg J. C., Witschi H. P. Pulmonary aryl hydrocarbon hydrolase: tobacco smoke-exposed guinea pigs. Toxicol. Appl. Pharmacol. 1977; 41: 433
   PubMedGoogle Scholar
• Oesch F., Schmassmann H., Ohnhaus E., Althaus U., Lorenz J. Monooxygenase, epoxide hydrolase, and glutathiones-transferase activities in human lung. Variation between groups of bronchogenic carcinoma and non-cancer patients and interindividual differences. Carcinogenesis 1980; 1: 827
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. The health consequences of smoking: the changing cigarette. U.S. Department of Health and Human Services. Public Health Services, Centers for Disease Control, Center for Health Promoting and Education, Office on Smoking and Health. 1981; 77–33, Section 2: pharmacology and toxicology; Section 3: cancer. Report of the Surgeon General. DHHS Publication No. (CDC) 81–50156
   Google Scholar
• Pelkonen O., Pasanen M., Kuha H., Gachalyi B., Kairaluoma M., Sotaniemi E. A., Park S. S., Frieddman F. K., Gelboin H. V. The effect of cigarette smoking on 7-ethoxyresorufinO-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies. Br. J. Clin. Pharmacol. 1986; 22: 125
   PubMed Web of Science ®Google Scholar
• Miller L. G. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin. Pharmacokinet. 1989; 17: 90
   PubMed Web of Science ®Google Scholar
• Sherson D., Sigsgaard T., Overgaard E., Loft S., Poulsen H. E., Jongeneelen F. J. Interaction of smoking, uptake of polycyclic aromatic hydrocarbons, and cytochrome P-450IA2 activity among foundry workers. Br. J. Ind. Med. 1992; 49: 197
   PubMedGoogle Scholar
• Rojas M., Camus A. M., Alexandrov K., Husgafvel-Pursiainen K., Anttila S., Vainio H., Bartsch H. Stereoselective metabolism of (-)-benzo[a]pyrene-7,8-diol by human lung microsomes and peripheral blood lymphocytes: effect of smoking. Carcinogenesis 1992; 13: 929
   PubMed Web of Science ®Google Scholar
• Thompson C. L., Mc Coy Z., Lambert J. M., Andries M. J., Lucier G. W. Relationships among benzo(a)pyrene metabolism, benzo(a)pyrenediol-epoxide: DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers. Cancer Res. 1989; 49: 6503
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Me tab. Rev. 1988; 19: 1
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Purification and characterization of xenobiotic-metabolizing enzymes from lung tissue. Pharmacol. Ther. 1990; 45: 299
   PubMed Web of Science ®Google Scholar
• Atta-Asafo-Adjei E., Lawton M. P., Philpot R. M. Cloning, sequencing, distribution, and expression inEscherichia coli of flavin-containing monooxygenase 1C1. J. Biol. Chem. 1993; 268: 9681
   PubMed Web of Science ®Google Scholar
• Williams D. E., Hale S. E., Muerhoff A. S., Masters B. S. S. Rabbit lung flavin-containing monooxygenase —purification, characterization, and induction during pregnancy. Mol. Pharmacol. 1985; 28: 381
   PubMed Web of Science ®Google Scholar
• Woodman P. W., Sarrif A. M., Heidelberger C. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2′-deoxyuridine. Cancer Res. 1980; 40: 507
   PubMedGoogle Scholar
• Schwartz P. M., Moir R. D., Hyde C. M., Turek P. J., Handschumacher R. E. Role of uridine phosphorylase in the anabolism of 5-fluorouracil. Biochem. Pharmacol. 1985; 34: 3585
   PubMed Web of Science ®Google Scholar
• Zimmerman M., Seidenberg J. Deoxyribosyl transfer. I. Thymidine phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J. Biol. Chem. 1964; 239: 2618
   PubMedGoogle Scholar
• Birnie G. D., Kroeger H., Heidelberger C. Studies of fluorinated pyrimidines. XVIII. The degradation of 5-fluoro-2′-deoxyuridine and related compounds by nucleoside phosphorylase. Biochemistry 1963; 2: 566
   PubMedGoogle Scholar
• Peters G. J., van Groeningen C. J., Laurensse E. J., Pinedo H. M. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa. Cancer 1991; 68: 1903
   PubMed Web of Science ®Google Scholar
• Heidelberger C. Fluorinated pyrimidines and their nucleosides. Antineoplastic and Immunosuppressive Agents Part II, Handbook of Experimental Pharmacology, A. C. Sartorelli, D. G. Johns. Springer-Verlag, Berlin 1975; 193
   Google Scholar
• Matthes E., Lehmann C., Scholz D., Rosenthal H. A., Langen P. Phosphorylation, anti-HIV activity and cytotoxicity of 3′-fluorothymidine. Biochem. Biophys. Res. Commun. 1988; 153: 825
   PubMed Web of Science ®Google Scholar
• Sommadossi J. P., Gewirtz D. A., Diasio R. B., Aubert C., Cano J. P., Goldman I. D. Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. J. Biol. Chem. 1982; 257: 8171
   PubMed Web of Science ®Google Scholar
• Naguib F. N. M., et al, Kouni M. H., Cha S. Enzymes of uracil catabolism in normal and neoplastic tissues. Cancer Res. 1985; 45: 5405
   PubMed Web of Science ®Google Scholar
• Ho D. H., Townsend L., Luna M. A., Bodey G. P. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res. 1986; 6: 781
   PubMed Web of Science ®Google Scholar
• Diasio R. B., Beavers T. L., Carpenter J. T. Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J. Clin. Invest. 1988; 81: 47
   PubMed Web of Science ®Google Scholar
• IARC, International Agency for Research on Cancer. Tobacco smoking. IARC Monographs of the Evaluation of the Carcinogenic Risk of the Chemicals to Humans. World Health Organization, International Agency for Research on Cancer. 1986; 38
   Google Scholar
• Kaiserman M. J., Rickert W. S. Carcinogens in tobacco smoke: benzo(a)pyrene from Canadian cigarettes and cigarette tobacco. Am. J. Public Health 1992; 82: 1023
   PubMed Web of Science ®Google Scholar
• Brunnemann K. D., Hoffmann D. Analytical studies on tobacco-specificN-nitrosamines in tobacco and tobacco smoke. Crit. Rev. Toxicol. 1991; 21: 235
   PubMed Web of Science ®Google Scholar
• Weyand E. H., Bevan D. R. Benzo(a)pyrene disposition and metabolism in rats following intratracheal instillation. Cancer Res. 1986; 46: 5655
   PubMed Web of Science ®Google Scholar
• Tornquist S., Wiklund L., Toftgard R. Investigation of absorption, metabolism kinetics and DNA-binding of intratracheally administered benzo[a]pyrene in the isolated, perfused rat lung: a comparative study between microcrystalline and particulate adsorbed benzo[a]pyrene. Chem. Biol. Interact. 1985; 54: 185
   PubMed Web of Science ®Google Scholar
• Gerde P., Muggenburg B. A., Hoover M. D., Henderson R. F. Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the beagle dog. I. The alveolar region. Toxicol. Appl. Pharmacol. 1993; 121: 313
   PubMed Web of Science ®Google Scholar
• Foth H., Mollière M., Kahl R., Jähnchen E., Kahl G. F. Covalent binding of benzo[a]pyrene in perfused rat lung following systemic and intratracheal administration. Drug Metab. Dispos. 1984; 12: 760
   PubMedGoogle Scholar
• Wiersma D. A., Roth C. A. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity. J. Pharmacol. Exp. Ther. 1983; 225: 121
   PubMed Web of Science ®Google Scholar
• Wiersma D. A., Roth R. A. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data. Mol. Pharmacol. 1983; 24: 300
   PubMed Web of Science ®Google Scholar
• Wiersma D. A., Braselton W. E., Roth R. A. The influence of flow on the metabolism of perfused benzo(a)pyrene by isolated rat lung. Chem. Biol. Interact. 1982; 43: 1
   Google Scholar
• Foth H., Kahl R., Kahl G. F. Pharmacokinetics of low doses of benzo(a)pyrene in the rat. Food Chem. Toxicol. 1988; 26: 45
   PubMed Web of Science ®Google Scholar
• Molliere M., Foth H., Kahl R., Kahl G. F. Metabolism of benzo(a)pyrene in the combined rat liver-lung perfusion system. Toxicology 1987; 45: 143
   PubMedGoogle Scholar
• Park J. Y., Bjeldanes L. F. Organ-selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: influence on covalent binding of benzo(a)pyrene to hepatic and pulmonary DNA in the rat. Chem. Biol. Interact. 1992; 83: 235
   PubMedGoogle Scholar
• Baldwin W. S., Leblanc G. A. The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P-450-mediated steroid hydroxylase activities in mice. Chem. Biol. Interact. 1992; 83: 155
   PubMedGoogle Scholar
• Athar M., Khan W. A., Mukhtar H. Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Senear mice. Cancer Res. 1989; 49: 5784
   PubMed Web of Science ®Google Scholar
• Das M., Khan W. A., Asokan P., Bickers D. R., Mukhtar H. Inhibition of polycyclic aromatic hydrocarbon-DNA adduct formation in epidermis and lungs of SENCAR mice by naturally occurring plant phenols. Cancer Res. 1987; 47: 767
   PubMed Web of Science ®Google Scholar
• Schmeltz I., Hoffmann D. Nitrogen-containing compounds in tobacco and tobacco smoke. Chem. Rev. 1977; 77: 295
   Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. The health consequences of smoking: nicotine addiction. II. Nicotine. Office on Smoking and Health, DHHS Publication. 1988; 88–8406, No. (CDC) 21pharmacokinetics, metabolism and pharmacodynamics. A Report of the Surgeon General, U.S. Department of Health and Human Services. Public Health Services, Centers for Disease Control, Center for Health Promoting and Education
   Google Scholar
• Armitage A. K., Turner D. M. Absorption of nicotine in cigarette and cigar smoke. Nature 1970; 226: 1231
   PubMed Web of Science ®Google Scholar
• Schievelbein H., Eberhardt R., Loeschenkohl K., Rahlfs V., Bedall F. K. Absorption of nicotine through the oral mucosa. I. Measurements of nicotine concentration in the blood after application of nicotine and total particulate matter. Agents Actions 1973; 3: 254
   PubMedGoogle Scholar
• Armitage A. K., Dollery C. T., George C. F., Houseman T. H., Lewis P. J., Turner D. M. Absorption and metabolism of nicotine from cigarettes. Br. Med. J. 1975; 4: 313
   PubMed Web of Science ®Google Scholar
• Russell M. A. H., Jarvis M., Iyer R., Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentration in smokers. Br. Med. J. 1980; 280: 972
   PubMed Web of Science ®Google Scholar
• Benowitz N. L., Jacob P. III, Nicotine and carbon monoxide uptake high- and low-yield cigarettes. Clin. Pharmacol. Ther. 1984; 36: 265
   PubMed Web of Science ®Google Scholar
• Booth J., Boyland E. The metabolism of nicotine into two optically active stereoisomers of nicotine-I'-oxide by animal tissues in vitro and by cigarette smokers. Biochem. Pharmacol. 1970; 19: 733
   PubMed Web of Science ®Google Scholar
• Mattammal M. B., Lakshmi V. M., Zenser T. V., Davis B. B. Lung prostaglandin H synthase and mixed function oxidase metabolism of nicotine. J. Pharmacol. Exp. Ther. 1987; 242: 827
   PubMed Web of Science ®Google Scholar
• Shigenaga M. K., Trevor A. J., Castagnoli N. Metabolism-dependent covalent binding of (S)-[5-3H]-nicotine to liver and lung microsomal macro-molecules. Drug Metab. Dispos. 1988; 16: 397
   PubMed Web of Science ®Google Scholar
• McGovern J. P., Lubaway W. C., Kostenbauder H. B. Uptake and metabolism of nicotine by the isolated perfused rabbit lung. J. Pharmacol. Exp. Ther. 1976; 190: 198
   Google Scholar
• Turner D. M., Armitage A. R., Briant R. H., Dollery C. T. Metabolism of nicotine by isolated perfused dog lung. Xenobiotica 1975; 5: 539
   PubMed Web of Science ®Google Scholar
• Rüdell U., Foth H., Kahl G. F. Eightfold induction of nicotine elimination in perfused rat liver by pretreatment with phenobarbital. Biochem. Biophys. Res. Commun. 1987; 148: 192
   PubMed Web of Science ®Google Scholar
• Foth H., Riidell U., Ritter G., Kahl G. F. Inhibitory effect of nicotine on benzo(a)pyrene elimination and marked pulmonary metabolism of nicotine in isolated perfused rat lung. Klin. Wochenschr 1988; 66(Suppl. XI)98
   PubMedGoogle Scholar
• Foth H., Looschen H., Neurath H., Kahl G. F. Nicotine metabolism in isolated perfused lung and liver of phenobarbital- and benzoflavone-treated rats. Arch. Toxicol. 1991; 65: 68
   PubMedGoogle Scholar
• Foth H., Walther U. I., Kahl G. F. Increased hepatic nicotine elimination after phenobarbital induction in the conscious rat. Toxicol. Appl. Pharmacol. 1990; 105: 382
   PubMedGoogle Scholar
• Petersen D. R., Norris K. J., Thompson J. A. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab. Dispos. 1984; 12: 725
   PubMed Web of Science ®Google Scholar
• Gorrod J. W., Jenner P. The metabolism of tobacco alkaloids. Essays Toxicol. 1975; 6: 35
   Web of Science ®Google Scholar
• Schievelbein H. Nicotine, resorption and fate. Pharmacol. Ther. 1982; 18: 233
   PubMed Web of Science ®Google Scholar
• Brandänge S., Lindblom L. The enzyme “aldehyde oxidase” is an iminium oxidase. Reaction with nicotine 1′(5′)iminium ion. Biochem. Biophys. Res. Commun. 1979; 91: 991
   PubMed Web of Science ®Google Scholar
• Hibbert A. R., Gorrod J. W. ComparativeN-oxidation of nicotine and cotinine by hepatic microsomes. Biological Oxidation of Nitrogen in Organic Molecules Gorrod, L.J. W. A. Damani. VCH Verlag, WeinheimGermany 1985; 246
   Google Scholar
• Peterson L. A., Trevor A., Castagnoli N. Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine 1′,5′-iminium species. J. Med. Chem. 1987; 30: 249
   PubMed Web of Science ®Google Scholar
• Bowman E. R., Mc Kennis H. Studies on the metabolism of (-)-cotinine in the human. J. Plmrmacol. Exp. Ther. 1962; 135: 306
   PubMed Web of Science ®Google Scholar
• Dagne E., Castagnoli N. Structure of hydroxycotinine, a nicotine metabolite. J. Med. Chem. 1972; 15: 356
   PubMed Web of Science ®Google Scholar
• Dagne E., Castagnoli N. Cotinine-N-oxide, a new metabolite of nicotine. J. Med. Chem. 1972; 15: 840
   PubMed Web of Science ®Google Scholar
• Benowitz N. L., Jacob P., III, Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 1993; 268: 296
   Google Scholar
• McCoy G. D., De Marco G. J., Koop D. R. Microsomal nicotine metabolism: a comparison of relative activities of six purified rabbit cytochrome P-450 isoenzymes. Biochem. Pharmacol. 1989; 38: 1185
   PubMed Web of Science ®Google Scholar
• Williams D. E., Shigenaga M. K., Castagnoli J. R. The role of cytochrome P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung. Drug Metab. Dispos. 1990; 18: 418
   PubMed Web of Science ®Google Scholar
• Nakayama H., Nakashima T., Kurogochi Y. Heterogeneity of hepatic nicotine oxidase. Biochem. Biophys. Acta 1982; 715: 254
   PubMedGoogle Scholar
• Kyerematen G. A., Morgan M., Warner G., Martin L. F., Vesell E. S. Metabolism of nicotine by hepatocytes. Biochem. Pharmacol. 1990; 40: 1747
   PubMedGoogle Scholar
• Nakayama H., Nakashima T., Kurogochi Y. Participation of cytochrome P-450 in nicotine oxidation. Biochem. Biophys. Res. Commun. 1982; 108: 200
   PubMedGoogle Scholar
• Stalhandske T. Effects of increased liver metabolism of nicotine on its uptake, elimination and toxicity in mice. Acta Physiol. Scand. 1970; 80: 222
   PubMedGoogle Scholar
• Törrönen R., Nousiainen U., Marselos M. Inducible aldehyde dehydrogenases in the hepatic cytosol of the rat. Acta Pharmacol. Toxicol. 1977; 41: 263
   PubMedGoogle Scholar
• Marselos M., Michalopoulos G. Phenobarbital enhances the aldehyde dehydrogenase activity of rat hepatocytes in vitro and in vivo. Acta Pharmacol. Toxicol. 1986; 59: 403
   PubMedGoogle Scholar
• Damani L. A., Pool W. F., Crooks P. A., Kaderlik R. K., Ziegler D. M. Stereoselectivity in the N'-oxidation of nicotine isomers by flavin-containing monooxygenase. Mol. Pharmacol. 1988; 33: 702
   PubMed Web of Science ®Google Scholar
• Cashman J. R., Park S. B., Yang Z. C., Wrighton S. A., Jacob P., Benowitz N. L. Metabolism of nicotine by human liver microsomes: stereoselective formation of transnicotine N'-oxide. Chem. Res. Toxicol. 1992; 5: 639
   PubMed Web of Science ®Google Scholar
• Williams D. E., Reed R. L., Kedzierski B., Ziegler D. M., Buhler D. R. The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine. Drug Metab. Dispos. 1989; 17: 380
   PubMed Web of Science ®Google Scholar
• Gombar C. T., Burak E., Harper N., Smith B. R. Pulmonary clearance of vasoactive drugs: N-oxidation of SK&F 86466 in the isolated perfused rat lung. J. Pharmacol. Exp. Ther. 1988; 245: 402
   PubMedGoogle Scholar
• Foth H., Walther U., Looschen H., Neurath H., Kahl G. F. Extrahepatic compared with hepatic metabolism of nicotine in the rat. Effects of Nicotine on Biological Systems, F. Adlkofer, K. Thurau. Adv. Pharmacol. Sci., Birkhäuser Verlag, Basel, Suisse 1991; 83
   Google Scholar
• Foth H., Aubrecht J., Höhne M., Walther U. I., Kahl G. F. Increased cotinine elimination and cotinine-N-oxide formation by phenobarbital induction in rat and mouse. Clin. Invest. 1992; 70: 175
   PubMedGoogle Scholar
• Bjercke R. J., Hammond D. K., Strobel H. W., Langone J. J. Interaction of cotinine with rat hepatic microsomal P-450. Comparison with metyrapone and immunomodulation of cotinine and metyrapone binding by monoclonal anti-cotinine antibodies. Drug Metab. Dispos. 1990; 18: 759
   PubMedGoogle Scholar
• Nwosu C. G., Crooks P. A. Species variation and stereoselectivity in the metabolism of nicotine enantiomers. Xenobiotica 1988; 12: 1361
   Google Scholar
• Castonguay A., Pepin P., Stoner G. D. Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Exp. Lung Res. 1991; 17: 485
   PubMed Web of Science ®Google Scholar
• Alworth W. L., Young-Sciame R., Hecht S. S. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P-450. Carcinogenesis 1993; 14: 1711
   PubMed Web of Science ®Google Scholar
• Belinsky S. A., White C. M., Devereux T. R., Swenberg J. A., Anderson M. W. Cell selective alkylation of DNA in rat lung following low-dose exposure to the tobacco-specific carcinogen 3-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 1987; 47: 1143
   PubMed Web of Science ®Google Scholar
• Belinsky S. A., Foley J. F., White C. M., Anderson M. W., Maronpot R. R. Dose-response relationship betweenO-methylguanine formation in clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 1990; 50: 3772
   PubMed Web of Science ®Google Scholar
• Belinsky S. A., Devereux T. R., White C. M., Foley J. F., Maronpot R. R., Anderson M. W. Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. Exp. Lung Res. 1991; 17: 263
   PubMed Web of Science ®Google Scholar
• Belinsky S. A., Devereux T. R., Foley J. F., Maronpot R. R., Anderson M. W. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 1992; 52: 3164
   PubMed Web of Science ®Google Scholar
• Smith T. J., Guo Z., Gonzalez F. J., Guengerich F. P., Stoner G. D., Yang C. S. Metabolism of 4-(methy lnitrosamino)-1-(3-pyridy 1)-1-butanone in human lung and liver microsomes and cytochrome P-450 expressed in hepatoma cells. Cancer Res. 1992; 52: 1757
   PubMed Web of Science ®Google Scholar
• Guo Z., Smith T. J., Thomas P. E., Yang C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P-450 enzymes in rats. Arch. Biochem. Biophys. 1992; 298: 279
   PubMed Web of Science ®Google Scholar
• Smith T. J., Guo Z., Hong J. Y., Ning S. M., Thomas P. E., Yang C. S. Kinetics and enzyme involvement in the metabolism of 4-(methylnitro-samino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis 1992; 13: 1409
   PubMed Web of Science ®Google Scholar
• Peterson L. A., Mathew R., Hecht S. S. Quantitation of microsomal α-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 1991; 51: 5495
   PubMed Web of Science ®Google Scholar
• Foth H., Schulze J., Richter E. NNK metabolism by isolated perfused rat lung. Nitroso Compounds: Biological Mechanisms, Exposures and Cancer Etiology, I. K. O'Neil, H. Barsch, 1991; 29, IARC Technical Report 11
   Google Scholar
• Schuller H. M., Castonguay A., Orloff M., Rossignol G. Modulation of the uptake and metabolism of 4-(methylnitrosamino)-1-(3-pyridy 1)-1-butanone by nicotine in hamster lung. Cancer Res. 1991; 51: 2009
   PubMedGoogle Scholar
• Xu Y., Ho C. T., Amin S. G., Han C., Chung F. L. Inhibition of tobacco-specific nitrosamine-in-duced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 1992; 52: 3875
   PubMed Web of Science ®Google Scholar
• Hong J. Y., Wang Z. Y., Smith T. J., Zhou S., Shi S., Pan J., Yang C. S. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis 1992; 13: 901
   PubMedGoogle Scholar
• Morse M. A., Amin S. G., Hecht S. S., Chung F. L. Effects of aromatic isothiocyanates on tumorigenicityO-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(pyridyi)-1-butanone in A/J mouse lung. Cancer Res. 1989; 49: 2894
   PubMed Web of Science ®Google Scholar
• Guo Z., Smith T. J., Wang E., Eklind K. I., Chung F. L., Yang C. S. Structure-activity relationships of aryl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic metabolizing enzymes in rats and mice. Carcinogenesis 1993; 14: 1167
   PubMed Web of Science ®Google Scholar
• Smith T. J., Guo Z., Li C., Ning S. M., Thomas P. E., Yang C. S. Mechanism of inhibition of 4-(methy lnitrosamin)-1-(3-pyridyl)-1-butanone bioacti vation in mouse by dietary phenylethyl isothiocyanates. Cancer Res. 1993; 53: 3276
   PubMed Web of Science ®Google Scholar
• Morse M. A., La Greca S. D., Shantu S. G., Amin G., Chung F. L. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition on NNK in A/J mice. Cancer Res. 1990; 50: 2613
   PubMed Web of Science ®Google Scholar
• Devereux T. R., Jones K., Bend J., Fouts J., Stratham C., Boyd M. R. In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (clara) and alveolar type II cells isolated from rabbit lung. J. Pharmacol. Exp. Ther. 1982; 220: 223
   PubMed Web of Science ®Google Scholar
• Slaughter S. R., Statham C. N., Philpot R. M., Boyd M. R. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system. J. Pharmacol. Exp. Ther. 1983; 224: 252
   PubMed Web of Science ®Google Scholar
• Czerwinski M., Mc Lemore T. K., Philpot R. M., Nhamburo P. T., Korzekwa K., Gelboin H. V., Gonzalez F. J. Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism. Cancer Res. 1991; 51: 4636
   PubMed Web of Science ®Google Scholar
• Verschoyle R. D., Philpot R. M., Wolf C. R., Dinsdale D. CYP4B1 activates 4-ipomeanol in rat lung. Toxicol. Appl. Pharmacol. 1993; 123: 193
   PubMed Web of Science ®Google Scholar
• Rowinsky E. K., Noe D. A., Ettinger D. S., Christian M. C., Lubejko B. G., Fishman E. K., Sartorius S. E., Boyd M. R., Donehower R. C. Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans. Cancer Res. 1993; 53: 1794
   PubMed Web of Science ®Google Scholar
• Abbruzzese J. L., Levin B. Treatment of advanced colorectal cancer. Hematol. Oncol. Clinics N. Am. 1989; 3: 135
   PubMedGoogle Scholar
• Cohen S. S., Flaks J. G., Barner H. D., Loeb M., Lichtenstein J. The mode of action of 5-fluorouracil and its derivatives. Proc. Natl. Acad. Sci. U.S.A. 1964; 44: 1004
   Google Scholar
• Hartmann K. U., Heidelberger C. Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase. J. Biol. Chem. 1961; 236: 3006
   PubMed Web of Science ®Google Scholar
• Glazer R. I., Hartman K. D. The effect of 5-fluorouracil on the synthesis and methylation of low molecular weight nuclear RNA in 1210 cells. Mol. Pharmacol. 1980; 17: 245
   PubMed Web of Science ®Google Scholar
• Armstrong R. D., Takimoto C. H., Cadman E. C. Fluoropyrimidine-mediated changes in small nuclear RNA. J. Biol. Chem. 1986; 261: 21
   PubMed Web of Science ®Google Scholar
• Doong S. L., Dolnick B. J. 5-Fluorouracil substitution alters pre-mRNA splicing in vitro. J. Biol. Chem. 1988; 263: 4467
   PubMed Web of Science ®Google Scholar
• Schuetz J. D., Collins J. M., Wallace H. J., Diasio R. B. Alteration of the secondary structure of newly synthesized DNA from murine bone marrow cells by 5-fluorouracil. Cancer Res. 1986; 46: 119
   PubMed Web of Science ®Google Scholar
• Ensminger W. D., Rosowsky A., Raso V., Levin D. C., Glode M., Come S., Steele G., Frei E. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res. 1978; 36: 3784
   Google Scholar
• Warren B. S., La Creta F. P., Kornhauser D. M., Williams W. M. Dose and flow dependence of 5-fluorouracil elimination by the isolated perfused rat liver. Cancer Res. 1987; 47: 5261
   PubMedGoogle Scholar
• Csaky K. G., La Creta F. P., Warren B. S., Williams W. M. 5-Fluoro-2′-deoxyuridine elimination by the isolated perfused rat liver. Cancer Res. 1988; 48: 3561
   PubMedGoogle Scholar
• Foth H., Kunellis E. M., Müseler T., Kahl G. F. Nonlinear elimination kinetics of 5-fluoro-2′-deoxyuridine in isolated perfused rat liver and isolated hepatocytes. J. Pharmacol. Exp. Ther. 1990; 254: 427
   PubMedGoogle Scholar
• Foth H., Hellkamp J., Kunellis E. M., Kahl G. F. Pulmonary elimination and metabolism of 5-fluoro-2′-deoxyuridine in isolated perfused rat lung and lung slices. Drug Metab. Dispos. 1990; 18: 1011
   PubMedGoogle Scholar
• Plagemann P. G. W., Wohlhueter R. M. Permeation of nucleosides, nucleic acid bases, and nucleotides in animal cells. Current Topics Membranes Transport, F. Bronner, A. Kleinzeller. Academic Press, San Diego 1980; 14: 225
   Google Scholar
• Belt J. A. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells. Mol. Pharmacol. 1983; 24: 479
   PubMed Web of Science ®Google Scholar
• Dagnino L., Paterson A. R. P. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells. Effect of inhibitors of equilibrative systems on the content and retention of nucleosides. Cancer Res. 1990; 50: 6549
   PubMed Web of Science ®Google Scholar
• Stoeckler J. D., Rosenfield C. G., Chu S. H., Li S. Y., Actons E. M., Ryan K. R., Parks R. E. Inhibition of nucleoside transport by nitroben-zylthioformycin analogs. Biochem. Pharmacol. 1990; 40: 615
   PubMed Web of Science ®Google Scholar
• Crawford C. R., Ng C. Y. C., Belt J. A. Isolation and characterization of an L1210 cell line retaining the sodium-dependent carriercif as its sole nucleoside transport activity. J. Biol. Chem. 1990; 265(13)730
   Google Scholar
• Kao Y. H., Yang C. Y., Chen R. R. L., Huang J. D. Pulmonary elimination of 5-fluorouracil in anaesthetized rats. J. Pharm. Sci. 1985; 74: 1095
   PubMedGoogle Scholar
• Andersson M., Domellöf L., Häggmark S., Johansson G., Reiz S., Gustavsson B. Cardiopulmonary hemodynamics and pharmacokinetics after hepatic intraarterial infusion of 5-fluorouracil (5-FU). An experimental study in the pig. Cancer Chemother. Pharmacol. 1988; 22: 251
   PubMedGoogle Scholar
• Maehara Y., Moriguchi S., Emi Y., Watanabe A., Kohnoe S., Tsujitani S., Sugimachi K. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas. Cancer 1990; 66: 156
   PubMedGoogle Scholar
• Hooftman R. N., Appelman Kuper C. F. Comparative sensitivity of histopathology and specific lung paramaters in the detection of lung injury. J. Appl. Toxicol. 1988; 8: 59
   PubMed Web of Science ®Google Scholar
• Mauderly J. L. Respiratory function responses of animals and man to oxidant gases and to pulmonary emphysema. J. Toxicol. Environ. Health 1984; 13: 345
   PubMed Web of Science ®Google Scholar
• Morrow P. E. Toxicological data on NOx: an overview. J. Toxicol. Environ. Health 1984; 13: 205
   PubMed Web of Science ®Google Scholar
• Iwata M., Takagi K., Satake T., Sugiyama S., Ozawa T. Mechanism of oxygen toxicity in rat lungs. Lung 1986; 164: 93
   PubMedGoogle Scholar
• Postlethwait E. M., Langford S. D., Bidani A. Transfer of NO2 through pulmonary epithelial lining fluid. Toxicol. Appl. Pharmacol. 1991; 109: 464
   PubMed Web of Science ®Google Scholar
• Lazenby A. J., Crouch E. C., Mc Donald J. A., Kuhn C. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am. Rev. Respir. Dis. 1990; 142: 206
   PubMed Web of Science ®Google Scholar
• Ginsburg E., Gram T. E., Trush M. A. A comparison of the pulmonary toxicity and chemo-therapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin. Cancer Chemother. Pharmacol. 1984; 12: 111
   PubMed Web of Science ®Google Scholar
• Chandler D. B., Barton J. C., Briggs D. D., Butler T. W., Kennedy J. I., Grizzle W. E., Fulmer J. D. Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster. Am. Rev. Respir. Dis. 1988; 137: 85
   PubMed Web of Science ®Google Scholar
• Phan S. H., Fantone J. C. Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysac-charide. Lab. Invest. 1984; 50: 587
   PubMed Web of Science ®Google Scholar
• Geismar L. S., Hennessey S., Reiser K. M., Last J. A. D-penicillamine prevents collagen accumulation in lungs of rats given bleomycin. Chest 1986; 89(Suppl. 3)153S
   Google Scholar
• Wang Q. J., Giri S. N., Hyde D. M., Li C. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem. Pharmacol. 1991; 42: 1115
   PubMed Web of Science ®Google Scholar
• Giri S. N., Graver D. F. Effects and levels of coenzyme Q10 in lung and liver in bleomycin-hamster model of lung fibrosis. Toxicol. Lett. 1991; 55: 47
   PubMed Web of Science ®Google Scholar
• Rannels D. E., Pegg A. E., Clark R. S., Addison J. L. Interaction of paraquat and amine uptake by rat lungs perfused. situ, Am. J. Physiol. 1985; 249: E506
   PubMed Web of Science ®Google Scholar
• Barnard J. W., Womack W. A., Smith S. M., Engerson T. D., Taylor A. E. Lung protection against paraquat is calcium dependent. J. Appl. Physiol. 1992; 72: 489
   Google Scholar
• Tomita M. Comparison of one-electron reduction activity against the bipyridylium herbicides, paraquat and diquat, in microsomal and mitochondrial fractions of liver, lung and kidney. (in vitro), Biochem. Pharmacol. 1991; 42: 303
   PubMedGoogle Scholar
• Kitazawa Y., Matsubara M., Takeyama N., Tanaka T. I. The role of xanthine oxidase in paraquat intoxication. Arch. Biochem. Biophys. 1991; 288: 220
   PubMed Web of Science ®Google Scholar
• Sata T., Kubota E., Misra H. P., Mojarad M., Pakbaz H., Said S. I. Paraquat-induced lung injury: prevention byN-tert-butyl-alpha-phenylnitrone, a free-radical spin-trapping agent. Am. J. Physiol. 1992; 262: L147
   PubMed Web of Science ®Google Scholar
• Minakata K., Suzuki O., Siato S., Harada N. Ascorbate radical levels in human sera and rat plasma intoxicated with paraquat and diquat. Arch. Toxicol. 1993; 67: 126
   PubMed Web of Science ®Google Scholar
• Schmid E. R., Bachelechner G., Varmuza K., Klus H. Determination of polycyclic aromatic hydrocarbons, polycyclic aromatic sulfur and oxygen heterocycles in cigarette smoke condensate. Fresenius Z. Anal. Chem. 1985; 322: 213
   Google Scholar
• Nocerini M. R., Carlson J. R., Yost G. S. Glutathione adduct formation with microsomally activated metabolites of the pulmonary alkylating and cytotoxic agent, 3-methylindole. Toxicol. Appl. Pharmacol. 1985; 81: 75
   PubMed Web of Science ®Google Scholar
• Ruangyuttikarn W., Skiles G. L., Yost G. S. Identification of a cysteinyl adduct of oxidized 3-methylindole from goat lung and human liver microsomal proteins. Chem. Res. Toxicol. 1992; 5: 713
   PubMed Web of Science ®Google Scholar
• Bray T. M., Kubow S. Involvement of free radicals in the mechanism of 3-methylindole-induced pulmonary toxicity: an example of metabolic activation in chemically induced lung disease. Environ. Health Perspect. 1985; 64: 61
   PubMed Web of Science ®Google Scholar
• Kahl R., Weinamm A., Weinke S., Hildebrandt A. G. Detection of oxygen activation and determination of the activity of antioxidants towards reactive oxygen species by use of the chemiluminogenic probes luminol and lucigenin. Arch. Toxicol. 1987; 60: 158
   PubMed Web of Science ®Google Scholar
• Bolton J. L., Thompson J. A. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes. Drug Metab. Dispos. 1991; 19: 467
   PubMed Web of Science ®Google Scholar
• Sydor W., Jr., Lewis K. F., Yang C. S. Effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene by mouse lung microsomes. Cancer Res. 1984; 44: 134
   PubMed Web of Science ®Google Scholar
• Minchin R. F., Ho P. C., Boyd M. R. Reductive metabolism of nitrofurantoin by rat lung and liver. in vitro, Biochem. Pharmacol. 1986; 35: 575
   PubMed Web of Science ®Google Scholar
• Jonen H. G., Oesch F., Piatt K. L. 4-Hydroxylation of nitrofurantoin in the rat. A 3-methyl-cholanthrene-inducible pathway of a relatively nontoxic compound. Drug. Metab. Disp. 1980; 8: 446
   PubMed Web of Science ®Google Scholar
• Jonen H. G. Reductive and oxidative metabolism of nitrofurantoin in rat liver. Naunyn-Schmiedeberger's Arch. Pharmacol. 1980; 315: 167
   PubMedGoogle Scholar
• Adam A., Smith L. L., Cohen G. M. An evaluation of the redox cycling potencies of paraquat and nitrofurantoin in microsomal and lung slice systems. Biochem. Pharmacol. 1990; 40: 1533
   PubMedGoogle Scholar
• Berger V., Berson A., Wolf C., Chachaty C., Fau D., Fromenty B., Pessayre D. Generation of free radicals during the reductive metabolism of nilutamide by lung microsomes: possible role in the development of lung lesions in patients treated with this anti-androgen. Biochem. Pharmacol. 1992; 43: 654
   PubMed Web of Science ®Google Scholar
• Nachtman J. P. Superoxide generation by 1-nitropyrene in rat lung microsomes. Res. Commun. Chem. Pathol. Pharmacol. 1986; 51: 73
   PubMedGoogle Scholar
• Kubow S., Wells P. G. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase. Mol. Pharmacol. 1989; 35: 504
   PubMed Web of Science ®Google Scholar
• Fisher A. B. Intermediary metabolism of the lung. Environ. Health Perspect. 1984; 55: 149
   PubMed Web of Science ®Google Scholar
• Gordon S. Macrophage neutral proteinases and defense of the lung. Fed. Proc. 1977; 36: 2707
   PubMedGoogle Scholar
• Brain J. D., Beck B. D. Bronchoalveolar lavage. Toxicology of Inhaled Materials, Handbook of Experimental Pharmacology, H. P. Witschi, J. D. Brain. Springer-Verlag, Berlin 1985; Vol. 75: 205
   Google Scholar
• O'Fiaherty J. T. Biology of disease: lipid mediators of inflammation and allergy. Lab. Invest. 1982; 47: 314
   PubMedGoogle Scholar
• Goetzl E. J. Mediators of immediate hypersensitivity derived from arachidonic acid. N. Engl J. Med. 1980; 303: 822
   PubMed Web of Science ®Google Scholar
• Haley P. J., Muggenburg B. A., Weissman D. N., Bice D. E. Comparative morphology and morphometry of alveolar macrophages from six species. Am. J. Anat. 1991; 191: 401
   PubMedGoogle Scholar
• Daniele R. P. Immunoglobulin secretion in the airways. Anna. Rev. Physiol. 1990; 52: 177
   PubMed Web of Science ®Google Scholar
• Sorokin S. P. The cells of the lung. Morphology of Experimental Respiratory Carcinogenesis, P. Nettesheim, M. G. Hanna, J. W. Deatherage. U.S. Atomic Energy Commission, Washington, DC 1970; 3
   Google Scholar
• Reid L. M. Secretory cells. Fed. Proc. 1977; 36: 2703
   PubMedGoogle Scholar
• Mariassy A. T., Plopper C. G., George J. A., Wilson D. W. Tracheobronchial epithelium of the sheep? IV. Lectin histochemical characterization of secretory epithelial cells. Anat. Rec. 1988; 222: 49
   PubMedGoogle Scholar
• Mariassy A. T., George J. A., Nishio J., Plopper C. G. Tracheobronchial epithelium of the sheep. III. Carbohydrate histochemical and cytochemi-cal characterization of secretory epithelial cells. Anat. Rec. 1988; 221: 540
   PubMedGoogle Scholar
• Plopper C. G., Halsebo J. E., Berger W. J., Sonstegard K. S., Nettesheim P. Distribution of nonciliated bronchiolar epithelial (clara) cells in intra- and extrapulmonary airways of the rabbit. Exp. Lung Res. 1983; 4: 79
   PubMedGoogle Scholar
• Plopper C. G., Alley J. L., Serabjit-Singh C. J., Philpot R. M. Cytodifferentiation of the nonciliated bronchiolar epithelial (Clara) cell during rabbit lung maturation: an ultrastructural and morphometric study. Am. J. Anat. 1983; 167: 329
   PubMedGoogle Scholar
• Mariassy A. T., Plopper C. G. Tracheobronchial epithelium of the sheep. II. Ultrastructural and morphometric analysis of the epithelial secretory cell types. Anat. Rec. 1984; 209: 523
   PubMedGoogle Scholar
• Jeffery P. K. The origins of secretions in the lower respiratory tract. Eur. J. Respir. Dis. 1987; 71(Suppl. 153)34
   Google Scholar
• Verdugo P. Goblet cells secretion and mucogenesis. Annu. Rev. Physiol. 1990; 52: 157
   PubMed Web of Science ®Google Scholar
• Wharton J., Polak J. M., Bloom S. R., Ghatei M. A., Solcia E., Brown M. R., Pearse A. G. E. Bombesin-like immunoreactivity in the lung. Nature 1978; 273: 769
   PubMed Web of Science ®Google Scholar
• Cutz E., Chan W., Track N. S. Bombesin, calcitonin and leu-enkephalin immunoreactivity in endocrine cells of human lung. Experientia 1981; 37: 765
   PubMedGoogle Scholar
• Hage E. Amine-handling properties of APUD-cells in the bronchial epithelium of human foetuses and in the epithelium of the main bronchi of human adults. Acta Pathol. Microbiol. Scand. 1973; 81: 64
   Google Scholar
• Lauweryns J. M., Cokelaere M., Theunynck P. Serotonin producing neuroepithelial bodies in rabbit respiratory mucosa. Science 1973; 180: 410
   PubMed Web of Science ®Google Scholar
• Mariassy A. T., Plopper C. G. Tracheobronchial epithelium of the sheep. I. Quantitative light-microscopic study of epithelial cell abundance, and distribution. Anat. Rec. 1983; 205: 263
   PubMedGoogle Scholar
• Devereux T. R., Serabjit-Singh C. J., Slaugher S. R., Wolf C. R., Philpot R. M., Fouts J. R. Identification of cytochrome P-450 isozymes in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung. Exp. Lung Res. 1981; 2: 221
   PubMed Web of Science ®Google Scholar
• Devereux T. R., Diliberto J. J., Fouts J. R. Cytochrome P-450 monooxygenase, epoxide hydrolase and flavin monooxygenase activities in Clara cells and alveolar type II cells isolated from rabbit. Cell Biol. Toxicol. 1985; 1: 57
   PubMed Web of Science ®Google Scholar
• Bond J. A., Harkema J. R., Russell V. I. Regional distribution of xenobiotic metabolizing enzymes in respiratory airways of dogs. Drug Metab. Dispos. 1988; 16: 116
   PubMed Web of Science ®Google Scholar
• Devereux T. R., Anderson M. W., Belinsky S. A. Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells, and the relationship to carcinogenicity. Cancer Res. 1988; 48: 4215
   PubMed Web of Science ®Google Scholar
• Davis M. L., Lewandowski J., Dodson R. F. Morphology and ultrastructure of the distal airway epithelium in the guinea pig. Anat. Rec. 1984; 209: 509
   PubMedGoogle Scholar
• Castranova V., Rabovsky J., Tucker J. H., Miles P. R. The alveolar type II epithelial cell: a multifunctional pneumocyte. Toxicol. Appl. Pharmacol. 1988; 93: 472
   PubMed Web of Science ®Google Scholar
• Bingle L., Bull T. B., Fox B., Guz A., Richards R. J., Tetley T. D. Type II pneumocytes in mixed cell culture of human lung: a light and electron microscopic study. Exp. Health Perspect. 1990; 85: 71
   PubMed Web of Science ®Google Scholar
• Toivonen H. J., Catravas J. D. Effects of blood flow on lung ACE kinetics: evidence for microvascular recruitment. J. Appl Physiol. 1991; 71: 2244
   PubMed Web of Science ®Google Scholar
• Ayars G. H., Altman L. C., Rosen H., Doyle T. The injurious effect of neutrophils on pneumocytes. in vitro, Am. Rev. Respir. Dis. 1984; 130: 964
   PubMedGoogle Scholar
• Linehan J. H., Bronikowski T. A., Dawson C. A. Kinetics of uptake and metabolism by endothelial cell from indicator dilution data. Ann. Biomed. Eng. 1987; 15: 201
   PubMedGoogle Scholar
• Harris T. R., Roselli R. J., Maurer C. R., Parker R. E., Pou N. A. Comparison of labeled propanediol and urea as markers of lung vascular injury. J. Appl. Physiol. 1987; 62: 1852
   PubMedGoogle Scholar
• Niemeier R. W. The isolated perfused lung. Environ. Health Perspect. 1984; 36: 35
   Google Scholar
• Mehendale H. M., Angevine L. S., Ohmiya Y. The isolated perfused lung — a critical evaluation. Toxicology 1981; 21: 1
   PubMed Web of Science ®Google Scholar
• Uhlig S., Wollin L. An improved setup for the isolated perfused rat lung. J. Pharmacol. Toxicol. Method 1994; 31: 85
   PubMedGoogle Scholar
• Postlethwait E. M., Bidani A., Evans J. M. The effect of NO 2 exposure on perfusate distribution in isolated rat lungs: pulmonary vs. bronchial circulation. Toxicol. Appl. Pharmacol. 1990; 106: 456
   PubMedGoogle Scholar
• Pan L. C., Lamé W., Morin D., Wilson D. W., Segal H. J. Red blood cell augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem perfused liver and lung preparations. Toxicol. Appl. Pharmacol. 1991; 110: 336
   PubMedGoogle Scholar
• Rhoades R. A. Isolated perfused lung preparation for studying altered gaseous environments. Environ. Health Perspect. 1984; 56: 43
   PubMed Web of Science ®Google Scholar
• Minchin R. F., Johnston M. R., Schuller H. M., Aiken M. A., Boyd M. R. Pulmonary toxicity of doxorubicin administered by in situ perfusions in dogs. Cancer 1988; 61: 1320
   PubMed Web of Science ®Google Scholar
• Byron P. R., Roberts S. R., Clark A. R. An isolated perfused lung preparation for the study of aerosolized drug deposition and absorption. J. Pharm. Sci. 1986; 75: 168
   PubMed Web of Science ®Google Scholar
• McDevitt D. G., Nies A. S. Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc. Res. 1976; 10: 494
   PubMed Web of Science ®Google Scholar
• Wicker P., Tarazi R. C. Importance of injection site for coronary blood flow determinations by microspheres in rats. Am. J. Physiol. 1982; 242: H94
   PubMed Web of Science ®Google Scholar
• Martins M. A., Shore S. A., Gerard N. P., Gerard C., Drazen J. M. Peptidase modulation of the pulmonary effects of tachykinins in tracheal segments superfused guinea pig lungs. J. Clin. Invest. 1990; 85: 170
   PubMed Web of Science ®Google Scholar
• Sparrow M. P., Mitchell H. W. Modulation by the epithelium of the extent of bronchial narrowing produced by substances perfused through the lumen. Br. J. Pharmacol. 1991; 103: 1160
   PubMedGoogle Scholar
• Freeman B. A., O'Neil J. J. Tissue slice in the study of lung metabolism and toxicology. Environ. Health Perspect. 1984; 56: 51
   PubMed Web of Science ®Google Scholar
• Emura M., Riebe M., Ochiai A., Aufderheide M., Germann P., Mohr U. New functional cell-culture approach to pulmonary carcinogenesis and toxicology. J. Cancer Res. Clin. Oncol. 1990; 116: 557
   PubMedGoogle Scholar
• Martin J., Dinsdale D., White I. N. H. Characterization of Clara and type II cells isolated from rat lung by fluorescence-activated flow cytometry. Biochem. J. 1993; 295: 73
   PubMed Web of Science ®Google Scholar
• Lacy S. A. Cytochrome P-450- and glutathione-associated enzyme activities in freshly isolated enriched lung cell fractions from β-naphthoflavone-treated male F344 rats. Toxicology 1992; 73: 147
   PubMed Web of Science ®Google Scholar
• Falzon M., Mc Mahon J. B., Schuller H. M. Xenobiotic-metabolizing enzyme activities in human non-small-cell derived lung cancer cell lines. Biochem. Pharmacol. 1986; 35: 563
   PubMed Web of Science ®Google Scholar
• Wiebel F. J., Kiefer F., Krupski G., Schuller H. M. Expression of glutathione S-transferase and phenol sulfotransferase, but not of UDP-glucuronosylt-ransferase, in the human lung tumor cell lines NCI-H322 and NCI-H358. Biochem, Pharmacol. 1986; 35: 1337
   PubMed Web of Science ®Google Scholar
• Heppleston A. G. Minerals, fibrosis, and the lung. Environ. Health Perspect. 1991; 94: 149
   PubMedGoogle Scholar